BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 38605220)

  • 1. Prognostic Value of Preoperative MRI-derived 3D Quantitative Tumor Arterial Burden in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization.
    Peng G; Huang XY; Wang YN; Cao XJ; Zhou X
    Radiol Imaging Cancer; 2024 May; 6(3):e230167. PubMed ID: 38607280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Controlling Nutritional Status Score on Mortality in Elderly Patients with Idiopathic Pulmonary Fibrosis.
    Iwanami Y; Ebihara K; Nakao K; Kubo R; Miyagi M; Nakamura Y; Sakamoto S; Kishi K; Okuni I; Ebihara S
    J Clin Med; 2024 May; 13(10):. PubMed ID: 38792367
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment-Related Lymphopenia is Possibly a Marker of Good Prognosis in Nasopharyngeal Carcinoma: a Propensity-Score Matching Analysis.
    Weng KG; Lei HK; Shen DS; Wang Y; Zhu XD
    Cancer Manag Res; 2024; 16():603-616. PubMed ID: 38855327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term oral administration of Huaier granules improves survival outcomes in hepatocellular carcinoma patients within Milan criteria following microwave ablation: a propensity score matching and stabilized inverse probability weighting analysis.
    Xie K; Ma M; Xu F
    Front Pharmacol; 2024; 15():1336347. PubMed ID: 38774215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Hepatocellular Carcinoma Treated with Conventional Transcatheter Arterial Chemoembolization: A Propensity Score Matched Analysis.
    Deng Z; Zhang W; Peng J; Gao L; Zhang C; Lei K; Gong J; Xiong B
    Cardiovasc Intervent Radiol; 2024 May; 47(5):592-603. PubMed ID: 38605220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
    Liu BJ; Gao S; Zhu X; Guo JH; Kou FX; Liu SX; Zhang X; Wang XD; Cao G; Chen H; Liu P; Zhu LZ; Xu HF; Yang RJ
    Biomed Res Int; 2021; 2021():6670367. PubMed ID: 34337041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomograms including the controlling nutritional status score in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation for prediction survival: a retrospective analysis.
    Chen Y; Xu WJ; Yang Y; Xin YJ; Zhang XY; Li X; Zhou X
    Br J Nutr; 2022 Nov; 128(10):1966-1974. PubMed ID: 34881693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Cohort Study.
    Shimose S; Kawaguchi T; Iwamoto H; Tanaka M; Miyazaki K; Ono M; Niizeki T; Shirono T; Okamura S; Nakano M; Suga H; Yamaguchi T; Yokokura Y; Noguchi K; Koga H; Torimura T
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32295043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy.
    Lin ZX; Ruan DY; Jia CC; Wang TT; Cheng JT; Huang HQ; Wu XY
    Clin Transl Oncol; 2020 Mar; 22(3):370-380. PubMed ID: 31201606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
    Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Artificial Intelligence-Based Tool for Data Analysis and Prognosis in Cancer Patients: Results from the Clarify Study.
    Torrente M; Sousa PA; Hernández R; Blanco M; Calvo V; Collazo A; Guerreiro GR; Núñez B; Pimentao J; Sánchez JC; Campos M; Costabello L; Novacek V; Menasalvas E; Vidal ME; Provencio M
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Value of Multiple Preoperative Objective Nutritional Indices for the Evaluation of Prognosis after Hepatectomy for Hepatocellular Carcinoma.
    Qian W; Xiao-Jian J; Jun H; Liang L; Xiao-Yong C
    Nutr Cancer; 2022; 74(9):3217-3227. PubMed ID: 35533004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring Systems.
    Müller L; Hahn F; Auer TA; Fehrenbach U; Gebauer B; Haubold J; Zensen S; Kim MS; Eisenblätter M; Diallo TD; Bettinger D; Steinle V; Chang DH; Zopfs D; Pinto Dos Santos D; Kloeckner R
    Front Oncol; 2022; 12():850454. PubMed ID: 35280804
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.